1142191-66-9 Usage
Uses
Used in Organic Synthesis:
5-Bromo-3-methoxypicolinic acid is used as a building block in organic synthesis for its ability to be incorporated into more complex organic molecules, facilitating the creation of novel compounds with specific properties.
Used in Coordination Compounds Preparation:
In the field of coordination chemistry, 5-Bromo-3-methoxypicolinic acid is used as a ligand in metal complexation reactions, contributing to the formation of coordination compounds with potential applications in catalysis, materials science, and other areas.
Used in Pharmaceutical Industry:
5-Bromo-3-methoxypicolinic acid is utilized as a key intermediate in the synthesis of pharmaceuticals, where its unique structure can be leveraged to develop new drugs with improved therapeutic effects and reduced side effects.
Used in Agrochemicals:
In the agrochemical sector, 5-Bromo-3-methoxypicolinic acid is employed in the development of new pesticides or herbicides, potentially enhancing crop protection and yield through its incorporation into effective and environmentally friendly products.
Used in Chemical Research and Development:
5-Bromo-3-methoxypicolinic acid is a valuable compound in chemical research and development, where it can be explored for new applications, understanding its reactivity, and optimizing its synthesis for industrial-scale production.
Check Digit Verification of cas no
The CAS Registry Mumber 1142191-66-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,2,1,9 and 1 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1142191-66:
(9*1)+(8*1)+(7*4)+(6*2)+(5*1)+(4*9)+(3*1)+(2*6)+(1*6)=119
119 % 10 = 9
So 1142191-66-9 is a valid CAS Registry Number.
1142191-66-9Relevant academic research and scientific papers
COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE
-
, (2020/12/01)
The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I), Formula (II), or Formula (III), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF
-
Paragraph 1219; 1221, (2017/01/23)
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.
